Preparation of ESAT6-Fc Fusion Protein and Its Therapeutic Efficacy and Immune Mechanisms in Allergic Asthma Mice via Intranasal Immunization
Molecules · 2025
DOI: 10.3390/molecules31010007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Jing Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathogenic Biology and Immunology, College of Basic Medical Science, Ningxia Medical University, Yinchuan 750004, China. Hauptthemen laut MEDLINE: Asthma, Recombinant Fusion Proteins, Antigens, Bacterial, Bacterial Proteins. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Ningxia Natural Science Foundation, Natural Science Foundation of Ningxia province, Innovation and Entrepreneurship Training Program for College Students.
Abstract (Originalsprache)
The respiratory mucosal system plays a critical role in the pathogenesis of allergic asthma (AA). Currently, therapeutic Fc fusion proteins are as a promising strategy for mucosal vaccine delivery systems. In this work, a plasmid encoding the Mycobacterium tuberculosis ESAT6-Fc fusion protein was successfully constructed, and high-purity ESAT6-Fc fusion protein was subsequently obtained. Administered via intranasal immunization in OVA-induced allergic asthma model mice, ESAT6-Fc fusion protein significantly alleviated airway inflammation and mucus production, and reduced the proportions of Th2 cells, Th17 cells, and eosinophils, while increasing the proportions of Th1 cells with no histopathological changes to major organs. To elucidate the underlying immune regulatory mechanisms of ESAT6, integrated transcriptomic and proteomic analyses were performed, revealing Th1/Th2 cell differentiation and Th17 cell differentiation as the two most significantly enriched pathways at both the gene and protein levels. CD3e (CD3E) and CD3g (CD3G), two essential subunits of the TCR–CD3 complex, were identified as core target factors. The validations from the ESAT6-Fc-treated AA lung tissues, as well as co-cultured TH0 cells from C57BL/6J mice and CD2.4 dendritic cells exposed to the ESAT6-Fc protein, were consistent with the aforementioned findings. ESAT6-Fc exhibits a safe profile with favorable efficacy against OVA-induced AA via intranasal immunization, and ESAT6 ameliorates AA by regulating the differentiation of Th0 cells into Th1 cells, which were closely associated with the down-regulation of CD3e and CD3g expression, presumably leading to the impairment of TCR–CD3 complex assembly. ESAT6-Fc fusion protein demonstrates promise as a potential safe intranasal immunotherapy agent for the treatment of AA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathogenic Biology and Immunology, College of Basic Medical Science, Ningxia Medical University, Yinchuan 750004, China.
- Key Laboratory of Prevention and Control of Common Infectious Diseases in Ningxia, Yinchuan 750004, China.
- Department of Natural Resource Management and Environmental Geography, College of Geographic Sciences and Planning, Ningxia University, Yinchuan 750021, China.
ORCID-Profile: Maiyan Hai, Qiaofeng Wan
Förderung
- the Ningxia Natural Science Foundation
- Natural Science Foundation of Ningxia province
- Innovation and Entrepreneurship Training Program for College Students
Zitieren
APA
Wang, J., Hai, M., Yang, Y., Wang, T., Zhang, W., Ma, R., Sun, M., Qin, Y., Yang, Y., Dong, Z., Yang, M., & Wan, Q. (2025). Preparation of ESAT6-Fc Fusion Protein and Its Therapeutic Efficacy and Immune Mechanisms in Allergic Asthma Mice via Intranasal Immunization. Molecules. https://doi.org/10.3390/molecules31010007
Vancouver
Wang J, Hai M, Yang Y, Wang T, Zhang W, Ma R, et al. Preparation of ESAT6-Fc Fusion Protein and Its Therapeutic Efficacy and Immune Mechanisms in Allergic Asthma Mice via Intranasal Immunization. Molecules. 2025. doi:10.3390/molecules31010007
BibTeX
@article{Wang2025,
author = {Wang, Jing and Hai, Maiyan and Yang, Yuxin and Wang, Tiansong and Zhang, Wei and Ma, Rui and Sun, Miao and Qin, Yanyan and Yang, Yuan and Dong, Zihan and Yang, Maosheng and Wan, Qiaofeng},
title = {Preparation of ESAT6-Fc Fusion Protein and Its Therapeutic Efficacy and Immune Mechanisms in Allergic Asthma Mice via Intranasal Immunization},
journal = {Molecules},
year = {2025},
doi = {10.3390/molecules31010007}
}
EUVIMED